Alvotech (ALVO) EBITDA Margin Growth (1y) (2023 - 2026)
Powered by 
Analysis
Alvotech (ALVO) EBITDA Margin Growth (1y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.56 Bn | 38.90 Bn | 2.15 Bn | -1,647.00 |
| 2 | Viatris | 19.17 Bn | 18.28 Bn | 1.46 Bn | -634.00 |
| 3 | Dr Reddys Laboratories | 9.88 Bn | 9.71 Bn | 396.53 Mn | -1,576.00 |
| 4 | Amneal Pharmaceuticals | 5.47 Bn | 5.35 Bn | 334.51 Mn | 93.00 |
| 5 | Bausch Health Companies | 2.35 Bn | 507.63 Mn | 2.10 Bn | 840.00 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -12,485.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 864.00 |
| 8 | Amphastar Pharmaceuticals | 996.39 Mn | 706.27 Mn | 93.47 Mn | -258.00 |
| 9 | Fennec Pharmaceuticals | 401.41 Mn | 360.16 Mn | 17.15 Mn | 3,802.00 |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12,485.00 |
| Mar 31, 2026 | -5,647.00 |
| Dec 31, 2025 | 32,721.00 |
| Sep 30, 2025 | -132,854.00 |
| Jun 30, 2025 | 25,890.00 |
| Mar 31, 2025 | 46,491.00 |
| Dec 31, 2024 | 158,664.00 |
| Jun 30, 2024 | -243,813.00 |
| Dec 31, 2023 | 693,317.00 |
| Aug 31, 2023 | 434,513.00 |
| Jun 30, 2023 | 175,769.00 |